PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Ebert, K.* ; Zwingenberger, G.* ; Barbaria, E.* ; Keller, S.* ; Heck, C.* ; Arnold, R.* ; Hollerieth, V.* ; Mattes, J.* ; Geffers, R.* ; Raimundez-Alvarez, E. ; Hasenauer, J. ; Luber, B.*

Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7).

BMC Cancer 20:1127 (2020)
Correction DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Following publication of the original article [1], the authors reported an error in the labeling of Table 5. The corrected Table 5 is given below.
Altmetric
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Other: Correction, Addition
Language english
Publication Year 2020
HGF-reported in Year 2021
ISSN (print) / ISBN 1471-2407
e-ISSN 1471-2407
Journal BMC Cancer
Quellenangaben Volume: 20, Issue: 1, Pages: , Article Number: 1127 Supplement: ,
Publisher BioMed Central
Publishing Place Campus, 4 Crinan St, London N1 9xw, England
Reviewing status Peer reviewed
Institute(s) Institute of Computational Biology (ICB)
POF-Topic(s) 30205 - Bioengineering and Digital Health
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-553800-001
DOI 10.1186/s12885-020-07642-2
WOS ID WOS:000595792400001
Scopus ID 85096360821
PubMed ID 33225928
Erfassungsdatum 2021-03-10
[➜Report correction]